JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
Labcorp
LH
$25B
| $43.1M | 0.01% |
428,315
-73,547
| -15% | -$7.05M |
2013 Q2
11 quarters
|
|
877
Western Alliance Bancorporation
WAL
$8.33B
| $42.9M | 0.01% |
1,285,495
+181,055
| +16% | +$5.66M |
2013 Q2
11 quarters
|
|
878
iShares MSCI World ETF
URTH
$8.24B
| $42.9M | 0.01% |
617,950
+351,345
| +132% | +$23.1M |
2015 Q3
2 quarters
|
|
|
AUD
879
DELISTED
Audacy, Inc.
AUD
| $42.9M | 0.01% |
4,050,441
+330,602
| +9% | +$3.52M |
2013 Q2
11 quarters
|
|
880
Nabors Industries
NBR
$1.21B
| $42.7M | 0.01% |
92,925
+63,611
| +217% | +$23.6M |
2013 Q2
11 quarters
|
|
881
State Street Technology Select Sector SPDR ETF
XLK
$130B
| $42.7M | 0.01% |
1,925,424
-1,927,060
| -50% | -$39.8M |
2013 Q2
11 quarters
|
|
882
Q2 Holdings
QTWO
$3.52B
| $42.6M | 0.01% |
1,773,208
+397,939
| +29% | +$8.54M |
2014 Q2
7 quarters
|
|
|
CYS
883
DELISTED
CYS Investments Inc.
CYS
| $42.6M | 0.01% |
5,236,335
+6,951
| +0.1% | +$51.2K |
2013 Q2
11 quarters
|
|
884
Consolidated Edison
ED
$38.2B
| $42.3M | 0.01% |
551,867
-372,267
| -40% | -$26.4M |
2013 Q2
11 quarters
|
|
885
Darling Ingredients
DAR
$9.93B
| $42.3M | 0.01% |
3,209,779
+2,719,416
| +555% | +$27.4M |
2013 Q2
11 quarters
|
|
886
Glacier Bancorp
GBCI
$5.72B
| $42.2M | 0.01% |
1,658,818
+95,972
| +6% | +$2.33M |
2013 Q2
11 quarters
|
|
|
ICPT
887
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $42.2M | 0.01% |
328,114
+12,117
| +4% | +$1.43M |
2014 Q1
8 quarters
|
|
888
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.13B
| $42.1M | 0.01% |
1,370,000
+895,000
| +188% | +$44.1M |
2015 Q2
3 quarters
|
|
889
Match Group
MTCH
$9.26B
| $42.1M | 0.01% |
3,805,521
+2,687,158
| +240% | +$30.8M |
2015 Q4
1 quarter
|
|
|
ENDP
890
DELISTED
Endo International plc
ENDP
| $42M | 0.01% |
1,493,234
-495,043
| -25% | -$23.4M |
2013 Q2
11 quarters
|
|
891
First Solar
FSLR
$18.8B
| $42M | 0.01% |
613,638
-100,098
| -14% | -$6.71M |
2013 Q2
11 quarters
|
|
892
Insight Enterprises
NSIT
$4.72B
| $41.9M | 0.01% |
1,462,791
-317,260
| -18% | -$7.99M |
2013 Q2
11 quarters
|
|
|
FNFG
893
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $41.9M | 0.01% |
4,325,922
-715,230
| -14% | -$6.92M |
2013 Q2
11 quarters
|
|
894
Hormel Foods
HRL
$11.1B
| $41.7M | 0.01% |
963,835
+618,175
| +179% | +$25.8M |
2013 Q2
11 quarters
|
|
|
STJ
895
DELISTED
St Jude Medical
STJ
| $41.6M | 0.01% |
757,089
+598,799
| +378% | +$32.6M |
2013 Q2
11 quarters
|
|
896
Amdocs
DOX
$6.07B
| $41.5M | 0.01% |
687,168
-114,049
| -14% | -$6.39M |
2013 Q2
11 quarters
|
|
|
RDS.B
897
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $41.5M | 0.01% |
842,956
+250,620
| +42% | +$11.2M |
2013 Q2
11 quarters
|
|
898
Graphic Packaging
GPK
$2.6B
| $41.4M | 0.01% |
3,222,729
+714,220
| +28% | +$8.68M |
2013 Q2
11 quarters
|
|
|
TWX
899
PUT
DELISTED
Time Warner Inc
TWX
| $41.4M | 0.01% |
570,500
+519,500
| +1,019% | +$35.8M |
2014 Q3
6 quarters
|
|
|
WBMD
900
DELISTED
WebMD Health Corp.
WBMD
| $41.4M | 0.01% |
660,767
-82,634
| -11% | -$4.43M |
2013 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.